Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.
The hallmark of neurofibromatosis type 1 (NF1) are multiple dermal neurofibromas. They show high inter- and intrafamilial variability for which the influence of modifying genes is discussed. NF1 patients presenting microdeletions spanning NF1 and several contiguous genes have an earlier onset and higher number of dermal neurofibromas than classical NF1 patients, pointing to one of the deleted genes as modifier. Expression analysis of 13 genes of the microdeletion region in dermal neurofibromas and other tissues revealed four candidates for the modification of neurofibroma formation: CENTA2, RAB11FIP4, C17orf79, and UTP6.
Institute of Human Genetics, University of Ulm, Ulm, Germany.
B
B
Bartelt-Kirbach
M
M
Wuepping
M
M
Dodrimont-Lattke
D
D
Kaufmann
D002886:Chromosomes, Human, Pair 17; D017353:Gene Deletion; D015870:Gene Expression; D006801:Humans; D019656:Loss of Heterozygosity; D009455:Neurofibroma / Q000235:genetics* / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000235:genetics / Q000473:pathology